Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 March 2020

New Respiratory Disease Articles from our Partners at Consultant 360

The Most Effective Approach for Diagnosing Acute Respiratory Failure Is Identified

Which diagnostic tool is most effective among patients with acute respiratory failure on mechanical ventilation in an intensive care unit? Authors of a new study compared the performance of pulmonary ultrasonography, chest radiography, and computed tomography to find out.

https://www.consultant360.com/exclusive/pulmonology/critical-care/most-effective-approach-diagnosing-acute-respiratory-failure

New Combination Therapy May Reduce OSA Severity

Can a combination of noradrenergic and antimuscarinic drugs improve the endotypic traits of patients with obstructive sleep apnea? Find out what the authors of a new study determined.

https://www.consultant360.com/pulmonology/sleep-apnea/new-combination-therapy-may-reduce-osa-severity

Ventricular Size May Impact Asthma Severity, Exacerbations

It is well known that pulmonary artery size is associated with respiratory exacerbations in patients with chronic obstructive pulmonary disease or cystic fibrosis. But does pulmonary artery size affect patients with asthma? Researchers may have found the answer.

https://www.consultant360.com/exclusive/pulmonology/asthma/ventricular-size-may-impact-asthma-severity-exacerbations

Combination Therapy May Aid Right Ventricular Function in Patients With Severe PAH

Previous studies have demonstrated that triple upfront combination therapy is an effective treatment for patients with severe pulmonary arterial hypertension. But what is the therapy’s impact on right ventricular function among this patient population?

https://www.consultant360.com/exclusive/pulmonology/pulmonary-arterial-hypertension/combination-therapy-may-aid-right-ventricular

Four Questions About the Burden of Asthma in the United States

The lead authors of a new study about the 20-year financial and health burdens of asthma—J. Mark FitzGerald, MD, and Mohsen Sadatsafavi, MD, PhD—answer Consultant360’s questions about its findings.

https://www.consultant360.com/exclusive/pulmonology/asthma/4-questions-about-burden-asthma-united-states